+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Pharmaceutical Intermediates Market by Type (GMP, Non GMP), Application (Analgesics, Antibiotics, Antipyretic), End-User - Forecast 2024-2030

  • PDF Icon

    Report

  • 195 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 4968712
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Pharmaceutical Intermediates Market size was estimated at USD 31.44 billion in 2023, USD 33.99 billion in 2024, and is expected to grow at a CAGR of 8.19% to reach USD 54.55 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Pharmaceutical Intermediates Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Pharmaceutical Intermediates Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Pharmaceutical Intermediates Market, highlighting leading vendors and their innovative profiles. These include Aceto Corporation, AGC Group, BASF SE, Codexis, Inc., Cycle Pharma, Dishman Group, Easter Chemical Corporation, Life Sciences Private Limited, Nectar Lifesciences Limited, Noah Chemicals, Proviron Holding NV, Sanofi S.A., SAREX, Vertellus Holdings LLC, and ZCL Chemicals Ltd.

Market Segmentation & Coverage

This research report categorizes the Pharmaceutical Intermediates Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • GMP
    • Non GMP
  • Application
    • Analgesics
    • Antibiotics
    • Antipyretic
    • Vitamins
  • End-User
    • Contract Manufacturing Organizations
    • Pharmaceutical Companies
    • Research Labs
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Pharmaceutical Intermediates Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Pharmaceutical Intermediates Market?
  3. What are the technology trends and regulatory frameworks in the Pharmaceutical Intermediates Market?
  4. What is the market share of the leading vendors in the Pharmaceutical Intermediates Market?
  5. Which modes and strategic moves are suitable for entering the Pharmaceutical Intermediates Market?

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Purchase of this report includes 1 year online access with quarterly updates

Purchase of this report includes 1 year online access with quarterly updates

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Pharmaceutical Intermediates Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing number of chronic and lifestyle-driven diseases
5.1.1.2. Surge in the funding by various drug-making companies
5.1.1.3. Rising adoption of pharmaceutical intermediates in clinical research
5.1.2. Restraints
5.1.2.1. Side effects related to the active pharmaceutical ingredients
5.1.3. Opportunities
5.1.3.1. Ongoing research and development activities in the pharmaceutical industry
5.1.3.2. Strategic alliances and investment for capacity expansion
5.1.4. Challenges
5.1.4.1. Strict rules and regulations to launch pharmaceutical drugs
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Pharmaceutical Intermediates Market, by Type
6.1. Introduction
6.2. GMP
6.3. Non GMP
7. Pharmaceutical Intermediates Market, by Application
7.1. Introduction
7.2. Analgesics
7.3. Antibiotics
7.4. Antipyretic
7.5. Vitamins
8. Pharmaceutical Intermediates Market, by End-User
8.1. Introduction
8.2. Contract Manufacturing Organizations
8.3. Pharmaceutical Companies
8.4. Research Labs
9. Americas Pharmaceutical Intermediates Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Pharmaceutical Intermediates Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Pharmaceutical Intermediates Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Aceto Corporation
13.1.2. AGC Group
13.1.3. BASF SE
13.1.4. Codexis, Inc.
13.1.5. Cycle Pharma
13.1.6. Dishman Group
13.1.7. Easter Chemical Corporation
13.1.8. Life Sciences Private Limited
13.1.9. Nectar Lifesciences Limited
13.1.10. Noah Chemicals
13.1.11. Proviron Holding NV
13.1.12. Sanofi S.A.
13.1.13. SAREX
13.1.14. Vertellus Holdings LLC
13.1.15. ZCL Chemicals Ltd.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. PHARMACEUTICAL INTERMEDIATES MARKET RESEARCH PROCESS
FIGURE 2. PHARMACEUTICAL INTERMEDIATES MARKET SIZE, 2023 VS 2030
FIGURE 3. PHARMACEUTICAL INTERMEDIATES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. PHARMACEUTICAL INTERMEDIATES MARKET DYNAMICS
FIGURE 7. PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. PHARMACEUTICAL INTERMEDIATES MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. PHARMACEUTICAL INTERMEDIATES MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. PHARMACEUTICAL INTERMEDIATES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. PHARMACEUTICAL INTERMEDIATES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 6. PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY GMP, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY NON GMP, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 9. PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANALGESICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY ANTIPYRETIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY VITAMINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 14. PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY RESEARCH LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. AMERICAS PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 18. AMERICAS PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 21. ARGENTINA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 22. ARGENTINA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 23. ARGENTINA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 24. BRAZIL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 25. BRAZIL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 26. BRAZIL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 27. CANADA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 28. CANADA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 29. CANADA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 30. MEXICO PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 31. MEXICO PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 32. MEXICO PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 37. ASIA-PACIFIC PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 38. ASIA-PACIFIC PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 39. ASIA-PACIFIC PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 41. AUSTRALIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 42. AUSTRALIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. AUSTRALIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 44. CHINA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 45. CHINA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. CHINA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 47. INDIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 48. INDIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. INDIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 50. INDONESIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 51. INDONESIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. INDONESIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 53. JAPAN PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 54. JAPAN PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. JAPAN PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 56. MALAYSIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 57. MALAYSIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. MALAYSIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 59. PHILIPPINES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 60. PHILIPPINES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. PHILIPPINES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 62. SINGAPORE PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 63. SINGAPORE PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. SINGAPORE PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 65. SOUTH KOREA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 66. SOUTH KOREA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. SOUTH KOREA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 68. TAIWAN PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 69. TAIWAN PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. TAIWAN PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 71. THAILAND PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 72. THAILAND PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. THAILAND PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 74. VIETNAM PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 75. VIETNAM PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. VIETNAM PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 81. DENMARK PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 82. DENMARK PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. DENMARK PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 84. EGYPT PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 85. EGYPT PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. EGYPT PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 87. FINLAND PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 88. FINLAND PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. FINLAND PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 90. FRANCE PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 91. FRANCE PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. FRANCE PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 93. GERMANY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 94. GERMANY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. GERMANY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 96. ISRAEL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 97. ISRAEL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. ISRAEL PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 99. ITALY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 100. ITALY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. ITALY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 102. NETHERLANDS PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 103. NETHERLANDS PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. NETHERLANDS PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 105. NIGERIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 106. NIGERIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. NIGERIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 108. NORWAY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 109. NORWAY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. NORWAY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 111. POLAND PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 112. POLAND PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. POLAND PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 114. QATAR PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 115. QATAR PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. QATAR PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 117. RUSSIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 118. RUSSIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 120. SAUDI ARABIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 121. SAUDI ARABIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. SAUDI ARABIA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 123. SOUTH AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 124. SOUTH AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 126. SPAIN PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 127. SPAIN PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. SPAIN PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 129. SWEDEN PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 130. SWEDEN PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 132. SWITZERLAND PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 133. SWITZERLAND PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. SWITZERLAND PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 135. TURKEY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 136. TURKEY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. TURKEY PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 138. UNITED ARAB EMIRATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 139. UNITED ARAB EMIRATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. UNITED ARAB EMIRATES PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM PHARMACEUTICAL INTERMEDIATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 144. PHARMACEUTICAL INTERMEDIATES MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 145. PHARMACEUTICAL INTERMEDIATES MARKET SHARE, BY KEY PLAYER, 2023
TABLE 146. PHARMACEUTICAL INTERMEDIATES MARKET LICENSE & PRICING

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Aceto Corporation
  • AGC Group
  • BASF SE
  • Codexis, Inc.
  • Cycle Pharma
  • Dishman Group
  • Easter Chemical Corporation
  • Life Sciences Private Limited
  • Nectar Lifesciences Limited
  • Noah Chemicals
  • Proviron Holding NV
  • Sanofi S.A.
  • SAREX
  • Vertellus Holdings LLC
  • ZCL Chemicals Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages195
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 33.99 Billion
Forecasted Market Value ( USD ) by 2030 $ 54.55 Billion
Compound Annual Growth Rate8.1%
Regions CoveredGlobal

Related Topics

Related Reports

Pharmaceutical Intermediates Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Pharmaceutical Intermediates Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 185 Pages
  • Global
From
Global API Intermediates Market by Type (Bulk Drug Intermediates, Chemical Intermediates), Raw Material (Carbonyl, Chloro, Nitrile), Application, End User - Forecast 2024-2030 - Product Image

Global API Intermediates Market by Type (Bulk Drug Intermediates, Chemical Intermediates), Raw Material (Carbonyl, Chloro, Nitrile), Application, End User - Forecast 2024-2030

  • Report
  • 199 Pages
  • Global
From
Pharmaceutical Intermediates - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029 - Product Image

Pharmaceutical Intermediates - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029

  • Report
  • 110 Pages
  • Global
From
Pharmaceutical Intermediates Global Market Report 2024 - Product Image

Pharmaceutical Intermediates Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Pharmaceutical Intermediates Global Market Opportunities and Strategies to 2033 - Product Image

Pharmaceutical Intermediates Global Market Opportunities and Strategies to 2033

  • Report
  • 326 Pages
  • Global
From

About the Pharmaceutical Intermediates Market

The Pharmaceutical Intermediates market is a segment of the pharmaceutical industry that focuses on the production of intermediate compounds used in the manufacture of drugs. These intermediates are typically produced in bulk and are used in the synthesis of active pharmaceutical ingredients (APIs). Pharmaceutical intermediates are typically produced in large quantities and are used in the production of a wide range of drugs, including antibiotics, antifungals, antivirals, and anti-inflammatory agents. The Pharmaceutical Intermediates market is highly competitive, with many companies offering a wide range of products. Some of the major players in the market include Merck, Pfizer, Novartis, Sanofi, and GlaxoSmithKline. These companies are involved in the production of a variety of intermediates, including amino acids, peptides, carbohydrates, and lipids. Additionally, many of these companies are involved in the development of new intermediates for the production of novel drugs. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.